Home › Thrombocytopenia › Massachusetts
Thrombocytopenia clinical trials in Massachusetts
3 studies for Thrombocytopenia are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Massachusetts General Hospital, Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235Apixaban in Thrombocytopenia
- Beth Israel Deaconess Medical Center, Boston
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT06886516Neonatal Platelet Transfusion Threshold Trial
- Beth Israel Deaconess Medical Center, Boston
RecruitingHealthy volunteers welcome
1 Hour – 48 Hours · All sexes · Updated Mar 25, 2026 · NCT06676904From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.